This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.
GENEYE® Systems deliver easy, rapid, and accurate pathogen detection at the point of care — transforming infectious disease diagnostics globally.
Explore Our ProductsFounded in 2007 as GenDxbio and restructured as GenDx Biotech in 2017, we are a pioneer in molecular point-of-care testing (POCT) technologies. Our mission is to drive global health through 10-minute, precision genomic diagnostics that defeat infectious threats.
Over the past two decades, our proprietary ERA Technology (Enzymatic Rapid Amplification) and GENEYE® Systems have become preferred solutions for rapid pathogen identification across clinical, public health, and field settings.
Leading Pathogen Detection Innovation: Charting the New Era of Precision Diagnostics.
Driving Global Health with 10-Minute ERA Diagnostics: Precision Genomics Detection Defeating Infectious Threats.
Flu, RSV, SARS-CoV-2, MP, MTB, and comprehensive respiratory panels.
HPV typing, STI panels, and compact detection assays.
Vaginitis microbial detection and reproductive health screening.
Detection of pathogens transmitted by ticks, mosquitoes, and other vectors.
Rapid identification of bloodstream and CNS infections.
Comprehensive GI pathogen panels for rapid diagnosis.
CARBA-5 and other resistance gene detection assays.
Super panels for rapid identification from positive blood cultures.
Enzymatic Rapid Amplification (ERA) is a proprietary isothermal nucleic acid amplification technology developed by GenDx Biotech. It enables ultra-fast, sensitive, and specific detection of pathogens in under 10 minutes — without the need for complex thermal cycling.
Discover our comprehensive range of single-target and multiplex assays powered by ERA Technology for rapid, accurate pathogen detection.
Rapid detection of Influenza A and B viruses in respiratory samples.
Sensitive detection of RSV in pediatric and adult respiratory infections.
10-minute nucleic acid test approved by NMPA for rapid MP detection.
Approved for import in Indonesia; rapid TB detection in clinical settings.
Multiplex detection of key respiratory pathogens including Flu, RSV, and SARS-CoV-2.
High-risk HPV genotyping for cervical cancer screening and monitoring.
Comprehensive detection of bacterial, viral, and parasitic GI pathogens.
Rapid identification of pathogens causing CNS infections from CSF samples.
Broad-range detection of bacteria, fungi, and resistance genes from positive blood cultures.
Multiplex detection of common fever-causing pathogens in tropical and endemic regions.
For product inquiries, distributor partnerships, or technical support, visit the official website to get in touch.
Visit Official WebsiteNotice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.
For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact [email protected] via your corporate email to cancel. We will cancel your inclusion within 3 business days.
如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系[email protected] 取消收录 我们将在3个工作日取消您的收录
Service Request: If you are other domain and want to be included, please contact [email protected]
如果您是其他域名合作 也请联系[email protected]